Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Senti Biosciences (SNTI) Other Operating Expenses (2021 - 2024)

Senti Biosciences (SNTI) has 4 years of Other Operating Expenses data on record, last reported at $8.1 million in Q4 2024.

  • For Q4 2024, Other Operating Expenses fell 17.21% year-over-year to $8.1 million; the TTM value through Sep 2025 reached $8.1 million, down 17.21%, while the annual FY2024 figure was $34.7 million, 40.34% down from the prior year.
  • Other Operating Expenses reached $8.1 million in Q4 2024 per SNTI's latest filing, up from $1000.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $29.8 million in Q3 2023 and bottomed at -$12.1 million in Q3 2021.
  • Average Other Operating Expenses over 4 years is $3.4 million, with a median of $1178.0 recorded in 2021.
  • The widest YoY moves for Other Operating Expenses: up 757.96% in 2023, down 444500.0% in 2023.
  • A 4-year view of Other Operating Expenses shows it stood at -$12.1 million in 2021, then surged by 112.6% to $1.5 million in 2022, then surged by 539.42% to $9.8 million in 2023, then decreased by 17.21% to $8.1 million in 2024.
  • Per Business Quant database, its latest 3 readings for Other Operating Expenses were $8.1 million in Q4 2024, $1000.0 in Q2 2024, and $9.8 million in Q4 2023.